Redcord: Perticipants will perform exercises in different plank positions using RedCord® while applying local vibration in:
* Supine plank position
* Prone plank position
* Lateral prone plank position
Control (Standard treatment): Participants will perform exercises in different plank positions:
Supine plank position Prone plank position Lateral prone plank position
Study summary
The study aims to evaluate the effectiveness of Redcord treatment for neurogenic bowel dysfunction in patients with multiple sclerosis. The main objectives are:
* Assess the impact of Redcord on bowel function and quality of life in multiple sclerosis patients.
* Compare the outcomes of Redcord treatment with standard care practices.
Participants will undergo Redcord therapy sessions and their bowel function will be monitored and compared to a control group receiving standard care. The study will measure improvements in bowel control, frequency, and overall patient satisfaction.
Eligibility
Sex
ALL
Min age
30 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria:
* People diagnosed with Multiple Sclerosis according to McDonald's criteria.
* EDSS less than 6 points.
* Willingness to participate.
Exclusion Criteria:
* People with cognitive impairment, which makes it difficult to understand the questionnaires properly.
* Pregnant women.
* Severe psychological or psychiatric pathology diagnosed.
Primary outcome measure(s)
Neurogenic Bowel Dysfunction score (NBDS) — baseline, 6, 12 and 24 weeks Improvement in bowel control, measured by the Neurogenic Bowel Dysfunction Score (NBD Score) over a period of 24 weeks.
Neurogenic Bowel Dysfunction score (NBDS) validated in Spanish is a questionnaire used for the clinical evaluation of colorectal and anal dysfunction. It is used to assess bowel dysfunction in neurological pathologies.
It quantifies the severity of bowel dysfunction in 4 categories: very mild (score 0 to 6), mild (score 7 to 9), moderate (score 10 to 13) and severe (score greater than or equal to 14). It consists of 10 items relating to frequency of bowel movements, presence of headache and/or sweating during defecation, use of medication for constipation, time used for each defecation, frequency of bowel movements by digital extraction, frequency of faecal incontinence, medication used for faecal incontinence, presence of anal incontinence, skin problems in the peri-anal area.
Trial sites (1)
Facility
City
Region
Status
University of Castilla La Macha
Toledo
Toledo
More University of Castilla-La Mancha trials in Spain
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
